ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 690 • 2012 ACR/ARHP Annual Meeting

    Molecular Analysis of 9G4+ Antibodies in Systemic Lupus Erythematosus

    Christopher Richardson1, Asiya Seema Chida2, Erin Fox1, Lin Silver1, Diana G. Adlowitz1, Scott Jenks3, Elise Palmer1, Christopher Tipton4 and Ignacio Sanz5, 1University of Rochester, Rochester, NY, 2Medicine, Emory University Medical Center, Atlanta, GA, 3Allergy, Immunology, and Rheumatology, Emory University School of Medicine, Atlanta, GA, 4Medicine/Rheumatology, Emory University, Atlanta, GA, 5Rheumatology, Emory University, Atlanta, GA

    Background/Purpose:  Elevated titers of serum autoantibodies expressing the 9G4 idiotype are highly specific for SLE and correlate with disease activity and clinical manifestations.  9G4+ antibodies…
  • Abstract Number: 651 • 2012 ACR/ARHP Annual Meeting

    Suicidal Ideation in Patients with Systemic Lupus Erythematosus: Incidence and Relationship with Anxiety/Depression Score Disease Activity and Organ Damage

    Chi Chiu Mok1, Kelly Chan1 and Paul Yip2, 1Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, 2Social Work and Social Administration, University of Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: To study the incidence of suicidal ideation in patients with SLE and its relationship with anxiety/depression score, disease activity and organ damage Methods: Consecutive…
  • Abstract Number: 652 • 2012 ACR/ARHP Annual Meeting

    Serum Rituximab Levels and Efficiency of B-Cell Depletion: Differences Between Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Venkat Reddy1, Sara Croca2, Delia Gerona3, Inmaculada De La Torre Ortega3, David A. Isenberg4, Maria Leandro2 and Geraldine Cambridge5, 1Rheumatology, University College London, London, United Kingdom, 2Centre for Rheumatology Research, Division of Medicine, University College London, London, United Kingdom, 3Rheumatology, Gregorio Marañón Hospital, Madrid, Spain, 4Centre for Rheumatology Research, Rayne Building, 4th Floor, Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom, 5Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom

    Background/Purpose: Variability in rituximab-induced B-cell depletion (BCD) occurs in a significant number of patients with Systemic Lupus Erythematosus (SLE) and to a lesser extent in…
  • Abstract Number: 653 • 2012 ACR/ARHP Annual Meeting

    Longitudinal Analysis of Plasma Factors and Disease Activity Identifies Von Willebrand Factor As A Biomarker of Lupus Flare

    Mikhail Olferiev1, Kyriakos A. Kirou1, Elena Gkrouzman1, Dorthe Lundsgaard2, Klaus S. Frederiksen3, Jan Fleckner4 and Mary K. Crow5, 1Hospital for Special Surgery, New York, NY, 2Inflammation Science, Biopharmaceuticals Research Unit, Novo Nordisk A/S, Måløv, Denmark, 3Novo Nordisk A/S, Søborg, Denmark, 4NovoNordisk, Copenhagen, Denmark, 5Department of Medicine, Hospital for Special Surgery, New York, NY

    Background/Purpose: Lupus, a chronic autoimmune disease, is characterized by a variable clinical course, with periods of active disease termed flares. The severity of flares can…
  • Abstract Number: 654 • 2012 ACR/ARHP Annual Meeting

    Incidence Studies of Systemic Lupus Erythematosus in Southern Sweden. Have the Tides Turned

    Ragnar Ingvarsson1, Andreas Jönsen2, Ola Nived3, Gunnar Sturfelt4 and Anders Bengtsson5, 1Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden, 2Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden, 3Department of Clinical Science, Lund University, Rheumatology, Lund, Sweden, 4Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Sweden, 5Department of Rheumatology, University Hospital Lund, Lund, Sweden

    Background/Purpose: The main objective was to study the incidence of Systemic Lupus Erythematosus (SLE) within a defined area in Southern Sweden over a period of…
  • Abstract Number: 655 • 2012 ACR/ARHP Annual Meeting

    Non-White Race, Younger Age, and Use of Primary and Gynecologic Care Are Associated with Higher Rates of Cervical Cancer Screening in Systemic Lupus Erythematosus Patients At a Public Hospital

    Jennifer Stichman1, Angela Keniston2, Joann Zell3, Jinoos Yazdany4, Itziar Quinzanos1 and Joel M. Hirsh5, 1Dept Medicine, Denver Health Med Ctr, Denver, CO, 2Department of Medicine, Denver Health and Hospital Authority, Denver, CO, 3Medicine, National Jewish Health, Denver, CO, 4Medicine, University of California, San Francisco, San Francisco, CA, 5Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO

    Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at increased risk of cervical dysplasia and persistent Human Papilloma Virus (HPV) infection. There are few prior…
  • Abstract Number: 656 • 2012 ACR/ARHP Annual Meeting

    Effects of Nelfinavir On Anti-dsDna Antibody Binding and Pro-Inflammatory Cytokine Gene Expression

    Maria Espinosa1, Julisa Patel2, Meggan Mackay3, Cynthia Aranow4 and Betty Diamond5, 1Pediatrics, Cohen Children's Hospital-North Shore LIJ, New Hyde Park, NY, 2Pediatric Rheumatology, Cohen Children's Hospital, New Hyde Park, NY, 3Autoimmune & Musculoskeletal Disease, Feinstein Institute for Medical Research, Manhasset, NY, 4Feinstein Institute for Medical Research, Manhasset, NY, 5Autoimmune & Musculoskeletal, Feinstein Institute Med Rsch, Manhasset, NY

    Background/Purpose: The hallmark of SLE is pathogenic autoantibody (aab) production that is closely associated with organ damage. Anti-dsDNA aab are specific to SLE; their deleterious…
  • Abstract Number: 657 • 2012 ACR/ARHP Annual Meeting

    Serial Screening Shows That 28% of Systemic Lupus Erythematosus Adult Patients Carry an Underlying Primary Immunodeficiency

    Sandro F. Perazzio1, Reinaldo Salomao2, Neusa P. Silva3, Magda Carneiro-Sampaio4 and Luis Eduardo C. Andrade5, 1Rheumatology, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Infectology, Federal University of Sao Paulo, Sao Paulo, Brazil, 3Rheumatology Div/Dept of Med, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 4Pediatrics, Instituto da Criança da Faculdade de Medicina da Universidade de São Paulo (FMUSP), Sao Paulo, Brazil, 5Rheumatology Division, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil

    Background/Purpose: Systemic Lupus Erythematosus (SLE) is known to be associated with deficiency of C1q, C4, and C2. There is high frequency of discoid lesions (2.7%)…
  • Abstract Number: 658 • 2012 ACR/ARHP Annual Meeting

    Up-Regulation of A Disintegrin and Metalloprotease with Thrombospondin Type I Repeats-13 Correlates with Ischemic Cerebrovascular Disease in Systemic Lupus Erythematosus Patients

    Consuelo Lopez de Padilla1, Molly Hein2, Cynthia S. Crowson3, Christopher Choo4, Abigail B. Green3, Michelle Petri5, Hatice Bilgic6, Emily Baechler Gillespie6 and Ann M. Reed7, 1Rheumatology/Immunology Research, Mayo Clinic, Rochester, MN, 2Mayo Clinic, Rochester, MN, 3Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 4Division of Rheumatology, Mayo Clinic, Rochester, MN, 5Johns Hopkins University School of Medicine, Baltimore, MD, 6University of Minnesota Medical School, Minneapolis, MN, 7Rheumatology, Mayo Clinic, Rochester, MN

    Background/Purpose: ADAMTS13 (A Disintegrin-like And Metalloprotease with ThromboSpondin type 1 motif) belongs to a recently described group of metalloproteinase enzymes which possess proteoglycanase and anti-angiogenic…
  • Abstract Number: 659 • 2012 ACR/ARHP Annual Meeting

    The Small Molecule Activator to ACE2 Prevents the Inhibition of ACE2 Activity by Autoantibodies

    Shiori Haga1, Yuko Takahashi2, Yukihito Ishizaka1 and Akio Mimori2, 1Department of Intractable Diseases, National Center for Global Health and Medicine, Research Institute, Tokyo, Japan, 2Division of Rheumatic Diseases, National Center for Global Health and Medicine, Tokyo, Japan

    Background/Purpose: Angiotensin-converting enzyme 2 (ACE2) is a member of renin-angiotensin system that plays a critical role in regulating blood pressure and cardiovascular function. It is…
  • Abstract Number: 660 • 2012 ACR/ARHP Annual Meeting

    Abnormal Neutrophil Development in Human Systemic Lupus Erythematosus

    Namrata Singh1, Mariana J. Kaplan2, Philip L. Cohen3 and Michael F. Denny3, 1Internal Medicine, Temple University, Philadelphia, PA, 2Systemic Autoimmunity Branch, National Institutes of Health/NIAMS, Bethesda, MD, 3Rheumatology, Temple University, Philadelphia, PA

    Background/Purpose: Recent research has increased the appreciation of the contributions of neutrophils to systemic lupus erythematosus (SLE).  An abnormal circulating pool of granulocytes has been…
  • Abstract Number: 661 • 2012 ACR/ARHP Annual Meeting

    Co-Localization of C-Reactive Protein, Immunoglobulin G and Complement in Renal Subendothelial Immune Deposits of Proliferative Lupus Nephritis Detected Using Immunogold Electron Microscopy

    Christopher Sjöwall1, Anders I. Olin2, Thomas Skogh3, Jonas Wetterö4, Mattias Mörgelin2, Ola Nived5, Gunnar Sturfelt6 and Anders A. Bengtsson7, 1Deparment of clinical and experimental medicine, Linkoping University, Linkoping, Sweden, 2Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden, Lund, Sweden, 3Deparment of clinical and experimental medicine, Linköping University, Linköping, Sweden, 4Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden, 5Department of Rheumatology, University Hospital Lund, Lund, Sweden, 6Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Sweden, 7Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden

    Background/Purpose: The pattern recognition molecules C-reactive protein (CRP) and complement protein 1q (C1q) are pivotal parts of the innate immune system and display relevant biological…
  • Abstract Number: 662 • 2012 ACR/ARHP Annual Meeting

    Increased C1q, C4 and C3 Deposition On Platelets in Patients with Systemic Lupus Erythematosus – A Possible Link to Venous Thrombosis?

    Christian Lood1, Sam Eriksson1, Birgitta Gullstrand2, Andreas Jönsen1, Gunnar Sturfelt3, Lennart Truedsson2 and Anders A. Bengtsson4, 1Department of Clinical Sciences Lund, Section of Rheumatology, Lund, Sweden, 2Department of Laboratory Medicine, Section of Microbiology, Immunology and Glycobiology, Lund University, Lund, Sweden, 3Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Sweden, 4Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) have an increased risk of developing vascular diseases (VD) such as myocardial infarction, stroke and venous thrombosis, which…
  • Abstract Number: 663 • 2012 ACR/ARHP Annual Meeting

    The Clinical Significance and Expression of P2X7 Purinergic Receptor in Peripheral Blood from  Patients with New-Oneset Systemic Lupus Erythematosus

    Xiangpei Li1, Meiyun Wang2, Jinhui Tao2, Xiaomei Li2 and Ning Yu1, 1Department of Rheumatology and Immunology,, Anhui Medical University Affiliated Provincial Hospital, Hefei, Anhui, China, 2Department of Rheumatology and Immunology, Anhui Medical University Affiliated Provincial Hospital, Hefei, Anhui, China

    Background/Purpose: P2X7 purinergic receptor (P2X7R) is encoded by a gene within the human SLE locus SLEB4. Extracellular adenosine triphosphate (ATP) regulates inflammatory cells by activation…
  • Abstract Number: 664 • 2012 ACR/ARHP Annual Meeting

    Estrogen Upregulates Interleukin-21 Production of Clusters of Differentiation 4 Positive T Lymphocytes in Patients with Systemic Lupus Erythematosus

    Jennifer Lee1, Daejun Kim1, Jae Ho Lee1, Seung Min Jung1, Mi-La Cho2, Seung-Ki Kwok1, Ji Hyeon Ju1, Kyung-Su Park1, Sung-Hwan Park1 and Ho-Youn Kim1, 1Division of Rheumatology, Department of Internal Medicine, School of Medicine, The Catholic University of Korea, Seoul, South Korea, 2Rheumatism Research Center, Catholic Research Institute of Medical Science, Rheumatic research center, Catholic University of Korea, Seoul, South Korea

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease in which various organs and tissues are damaged through abnormal immune responses mediated by tissue-binding autoantibodies…
  • « Previous Page
  • 1
  • …
  • 2375
  • 2376
  • 2377
  • 2378
  • 2379
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology